Francisco M Heralde 3rd
Overview
Explore the profile of Francisco M Heralde 3rd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tan J, Bilog M, Profit A, Heralde 3rd F, Desamero R
Biochim Biophys Acta Gen Subj
. 2024 Dec;
1869(2):130742.
PMID: 39681275
Atherosclerosis, the major underlying cause of cardiovascular disease, is believed to arise from the accumulation of low-density lipoprotein (LDL) in the arterial subendothelial space, ultimately leading to plaque formation. It...
2.
Barcena A, Perez J, Bernardino M, Damasco J, San Valentin E, Klusman C, et al.
Biomater Adv
. 2024 Sep;
166():214052.
PMID: 39341164
Background: Mesenchymal stem cells (MSCs) have emerged as novel therapies for supporting arteriovenous fistula (AVF) maturation, and bioresorbable polymeric scaffolds have enabled sustained MSC delivery into maturing AVFs. However, the...
3.
Llamas-Clark 3rd E, Lumandas M, Villarico D, Nicolasora A, Cagayan M, Baja E, et al.
Acta Med Philipp
. 2024 Sep;
58(15):32-38.
PMID: 39308885
Objectives: To validate a method in detecting SARS-CoV-2 via RT-qPCR in pregnant and non-pregnant samples other than nasopharyngeal swabs and/or oropharyngeal swabs such as cervical, rectal, amniotic fluid, placental, umbilical...
4.
Francisco A, Reyes J, Tabios I, Cruz C, Ang M, Heralde 3rd F, et al.
PLoS One
. 2023 Dec;
18(12):e0293046.
PMID: 38039314
Human adenovirus (HAdV), particularly the HAdV type 5 (HAdV-5), has been extensively utilized in the development of vector vaccines due to its high immunogenicity, good safety profile, and ease of...
5.
Barcena A, Perez J, Damasco J, Bernardino M, San Valentin E, Klusman C, et al.
Int J Mol Sci
. 2023 Jul;
24(14).
PMID: 37511512
Mesenchymal stem cell (MSC)-seeded polymeric perivascular wraps have been shown to enhance arteriovenous fistula (AVF) maturation. However, the wraps' radiolucency makes their placement and integrity difficult to monitor. Through electrospinning,...
6.
Barcena A, Perez J, Bernardino M, Damasco J, Cortes A, Del Mundo H, et al.
Adv Healthc Mater
. 2023 Jul;
12(26):e2300960.
PMID: 37395729
Bioresorbable perivascular scaffolds loaded with antiproliferative agents have been shown to enhance arteriovenous fistula (AVF) maturation by inhibiting neointimal hyperplasia (NIH). These scaffolds, which can mimic the three-dimensional architecture of...
7.
Grijaldo S, Alvarez M, Heralde 3rd F, Nacario R, Lebrilla C, Rabajante J, et al.
ACS Omega
. 2023 Jun;
8(23):20303-20312.
PMID: 37332828
Glycoproteins are an underexploited drug target for cancer therapeutics. In this work, we integrated computational methods in network pharmacology and docking approaches to identify phytochemical compounds that could potentially interact...
8.
Alvarez M, Zhou Q, Tena J, Barboza M, Wong M, Xie Y, et al.
Cancers (Basel)
. 2023 Mar;
15(5).
PMID: 36900350
Lung cancer is the leading cause of cancer death and non-small cell lung carcinoma (NSCLC) accounting for majority of lung cancers. Thus, it is important to find potential biomarkers, such...
9.
Alvarez M, Zhou Q, Tena J, Lebrilla C, Completo G, Heralde 3rd F, et al.
ACS Omega
. 2022 Nov;
7(44):40230-40240.
PMID: 36385894
Aberrant glycosylation has been extensively reported in cancer, with fundamental changes in the glycosylation patterns of cell-surface and secreted proteins largely occurring during cancer progression. As such, serum glycan and...
10.
Barcena A, Perez J, Liu O, Mu A, Heralde 3rd F, Huang S, et al.
Biomolecules
. 2022 Oct;
12(10).
PMID: 36291576
An arteriovenous fistula (AVF) is the preferred vascular access for chronic hemodialysis, but high failure rates restrict its use. Optimizing patients' perioperative status and the surgical technique, among other methods...